A device and a method for creating and/or maintaining an obstruction free upper respiratory passages. The device is configured to fit under the chin of a subject adjacent to the subject's neck at an external location corresponding approximately with the subject's soft tissue associated with the neck's anterior triangle. The device is capable of exerting negative pressure on the surface of a subject's neck, displacing the soft tissue forward and enlarging the airway.

A system and accompanying assembly, of integrated or modular construction, for inflating and monitoring pressure within a retaining cuff including a housing having a pressure chamber connected in fluid communication with a fluid pressure source and a fluid communicating connection with the retaining cuff. Associated control circuitry includes a pressure sensor disposable in fluid communication with the pressure chamber and the retaining cuff, via the fluid communicating connection and structured to concurrently determine and monitor pressure within the pressure chamber and the retaining cuff. The control circuitry is cooperatively structured with the pressure sensor and other operative components to establish dynamic multilevel sampling capabilities, calibration parameters stored within the control circuitry prior to use and limited or single use capabilities of the assembly.

The present invention relates to a medicament delivery device comprising a housing (10), which housing is arranged to accommodate a medicament container (20); a power unit (88) comprising: a drive force element (98), an actuation unit (90, 102) operably connected to said drive force element (98); which actuation unit (90, 102) is movable, upon activation of said drive force element (98), for expelling a dose of medicament from said medicament container (20); a monitoring unit (130) provided with an electrical power source (140) for operating said monitoring unit (130). The invention is characterised in that the medicament delivery device further comprises an activation element (160) operably connected to said actuation unit (90, 102), to said monitoring unit (130) and to said electrical power source (140), wherein said activation element (160) is arranged to allow connection between said electrical power source (140) and said monitoring unit (130) when said actuation unit (98, 102) is moved.

An emotional or mental belief system reprogramming system is disclosed. The system includes a digital framework including a pattern recognition module configured to identify and recommend reprogramming and alter a health status of a user, the digital framework includes (1) a digitally recorded library of human emotions, unconscious agendas, perceptions, beliefs, and mindsets of a control group of users selected from a population of users (2) a question engine configured to interrogate the user using a library of predetermined questions and to identify a plurality of underlying unconscious agendas of the user that generate behavior of the user and associated negative emotions of the user, (3) an expressive, experiential digital agent having digitized color, gestures, expressions, movements, emotions, beliefs, intent, intuition, and haptic effects, the digital agent configured to interact with the user in real time, to ask questions, to engage the user.

Various embodiments are described herein for a controller for controlling the operation of a breathing assistance device that provides breathing assistance to a user. The controller comprises a processor that generates a respiratory index value that is determined during a current monitoring time period to detect a respiratory failure, or predict the respiratory failure when at least one PSG signal is measured. The respiratory index value is compared to a threshold to determine if the control signal needs to be updated to reduce or eliminate respiratory failure that the user is currently experiencing or to prevent a predicted respiratory failure from occurring.

An electronic system for a drug delivery device including a dose setting and drive mechanism, a communication unit, an electronic control unit, and an electrical use detection. The dose setting and drive mechanism includes a first member and a second member that move relative to each other at least in the dose delivery operation and/or in the dose setting operation of the drug delivery device. The electronic system has a first state in which the communication unit is not activated and a second state in which the communication unit is activated. The electrical use detection unit is configured to generate a first signal indicative that the user has commenced or finished the relative movement between the first member and the second member. The electronic control unit is configured to switch the electronic system from the first state into the second state in response to the first signal.

A novel embodiment of a drive mechanism for use in a pump, for example, of the type that would be used in a wearable drug delivery system, comprises, a cylindrically-shaped slider element configured with a channel on a circumferential surface thereof defining one or more zig-zag-shaped tracks therethrough. One or more pegs are engaged within the tracks, such that a back and forth longitudinal motion of the slider element along a radial axis of the cylinder causes movement of the pegs along one of the tracks through the channel, thus providing a movement of the pegs around the circumference of the cylinder which imparts a rotational motion to a header element disposed co-axially with the slider. The header element is in turn connected to a gear train, for example, a planetary gear box, which is coupled to the pump via a linkage or other type of mechanism.

An inhaler includes a mouthpiece cover, a pressure sensor, a first indicator and a second indicator. The first indicator may be configured to indicate based on a state of the cover, and the second indicator may be configured to indicate based on an output of the pressure sensor. For example, when the mouthpiece cover opens, the first indicator may illuminate and a dose of medication may be transferred from a reservoir to a dosing cup. The second indicator may illuminate if an amount of inhaled medication reaches a predetermined threshold for successful inhalation.

An electronic cigarette and a method of controlling the electronic cigarette are disclosed, the electronic cigarette includes a controller; and at least one air pressure sensor coupled with the controller; the at least one air pressure sensor is configured for detecting a first air pressure in an air flow path of the electronic cigarette and a second air pressure of an ambient atmosphere where the electronic cigarette is located, and sending the first air pressure and the second air pressure to the controller; the controller is configured for receiving the second air pressure and the first air pressure and controlling an atomizer to be on or off based on a pressure differential between the first air pressure and the second air pressure.

A mist inhaler device (200) for generating a mist including a therapeutic for inhalation by a user. The device includes a mist generator device (201) and a driver device (202). The driver device (202) is configured to drive the mist generator device (201) at an optimum frequency to maximise the efficiency of mist generation by the mist generator device (201).